STOCK TITAN
  1. Home
  2. Sec-filings
  3. IQV
  4. [8-K] IQVIA HOLDINGS INC. Reports Material Event

IQVIA prices $2B senior notes due 2034 at 6.375%

IQVIA plans a $2 billion 6.375% senior notes due 2034 offering to refinance 2026 notes and reduce revolving credit facility borrowings.

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IQVIA HOLDINGS INC. (IQV) reported that its wholly owned subsidiary, IQVIA Inc., has priced a private offering of $2,000,000,000 aggregate principal amount of senior notes due March 15, 2034, bearing interest at 6.375% per annum and paying semi-annual interest starting March 15, 2027.

The company plans to use the net proceeds to redeem in full its existing Senior 5.000% Notes due 2026, repay a portion of the outstanding indebtedness under its revolving credit facility, and pay fees and expenses related to the notes offering. The issuance of the notes is expected to occur on or about September 23, 2026, subject to customary closing conditions, and is being conducted as a private offering under Rule 144A and Regulation S.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Senior notes offering size $2,000,000,000 aggregate principal amount Senior notes due 2034 issued by IQVIA Inc.
Interest rate on new senior notes 6.375% per annum Coupon on senior notes due 2034
Maturity date of new notes March 15, 2034 Stated maturity of senior notes
First interest payment date March 15, 2027 First semi-annual interest payment on new notes
Existing notes to be redeemed Senior 5.000% Notes due 2026 Debt to be redeemed in full with proceeds
Expected issuance date On or about September 23, 2026 Anticipated closing of senior notes offering
senior notes financial
"through an offering of senior notes due 2034"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
revolving credit facility financial
"to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility"
A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.
Rule 144A regulatory
"in the United States in reliance on Rule 144A under the Securities Act"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
Regulation S regulatory
"outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
qualified institutional buyers financial
"offered only to persons reasonably believed to be qualified institutional buyers"
Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.
Securities Act of 1933 regulatory
"not been registered under the Securities Act of 1933, as amended"

FAQ

What type of financing did IQVIA (IQV) announce in this 8-K?
IQVIA announced that its subsidiary, IQVIA Inc., priced a $2,000,000,000 offering of senior notes due 2034. The notes bear interest at 6.375% per annum and are being offered in a private placement under Rule 144A and Regulation S.

What will IQVIA (IQV) use the $2 billion senior notes proceeds for?
IQVIA plans to use the proceeds to redeem in full its Senior 5.000% Notes due 2026, repay a portion of the outstanding indebtedness under its revolving credit facility, and pay fees and expenses related to the notes offering.

What is the interest rate and maturity of IQVIA’s new senior notes due 2034?
The new senior notes will bear interest at 6.375% per annum and mature on March 15, 2034, unless earlier repurchased or redeemed in accordance with their terms. Interest will be paid semi-annually on March 15 and September 15 of each year, beginning March 15, 2027.

When is IQVIA (IQV) expected to close the $2 billion notes offering?
The issuance of the senior notes is expected to occur on or about September 23, 2026, subject to the satisfaction of customary closing conditions, as described in IQVIA’s announcement.

How are IQVIA’s new senior notes being offered and who can buy them?
The notes are being offered only to qualified institutional buyers in the United States under Rule 144A and to non-U.S. investors outside the United States under Regulation S. The notes are not registered under the Securities Act of 1933.

What existing debt instruments are affected by IQVIA’s new notes offering?
IQVIA intends to redeem in full its Senior 5.000% Notes due 2026 and repay a portion of the outstanding indebtedness under its revolving credit facility using the proceeds from the new 2034 senior notes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001478242 0001478242 2026-09-09 2026-09-09
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 9, 2026

 

 

IQVIA HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35907   27-1341991

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

2400 Ellis Road

Durham, North Carolina

   27703
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (919) 998-2000

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

  

Trading
Symbol

  

Name of Each Exchange

on which Registered

Common Stock, par value $0.01 per share   “IQV”   New York Stock Exchange

 

 
 

Item 8.01

Other Events

On September 9, 2026, IQVIA Holdings Inc. (the “Company”) issued a press release announcing that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 in gross proceeds through an offering of senior notes due 2034 (the “Notes Offering”) and intends to use the proceeds to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On September 9, 2026, the Issuer entered into a purchase agreement with the representative of the purchasers named therein, relating to the issuance and sale of $2,000,000,000 in aggregate principal amount of senior notes due 2034 bearing interest at a rate of 6.375% per annum. The consummation of the Notes Offering, which is expected to occur on or about September 23, 2026, is subject to the satisfaction of customary closing conditions. The Company also issued a press release announcing the pricing of the Notes Offering. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit
No.		    Description
99.1    Launch press release dated September 9, 2026
99.2    Pricing press release dated September 9, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 9, 2026

 

IQVIA HOLDINGS INC.
By:  

/s/ Eric M. Sherbet

  Eric M. Sherbet
  Executive Vice President and General Counsel

Exhibit 99.1

IQVIA Announces Offering of Senior Notes

September 9, 2026

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the “Notes”).

The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other customary conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes to be offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act. Any offer of the Notes will be made only by means of a private offering memorandum.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

Forward Looking Statements

Certain statements in this press release are forward-looking statements. These statements involve a number of risks, uncertainties and other factors, including the failure to consummate the Notes offering, and potential changes in market conditions that could cause actual results to differ materially.

IQVIAFIN

Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)

+1.973-541-3558

Exhibit 99.2

IQVIA Announces Pricing of Senior Notes

September 9, 2026

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering.

The Notes will bear interest at a rate of 6.375% per annum and will pay interest semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2027. The Notes will mature on March 15, 2034, unless earlier repurchased or redeemed in accordance with their terms. The issuance of the Notes is expected to occur on or about September 23, 2026, subject to the satisfaction of customary closing conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes to be offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act. Any offer of the Notes will be made only by means of a private offering memorandum.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

Forward Looking Statements

Certain statements in this press release are forward-looking statements. These statements involve a number of risks, uncertainties and other factors, including the failure to consummate the Notes offering, and potential changes in market conditions that could cause actual results to differ materially.

IQVIAFIN

Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)

+1.973-541-3558

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Press Releases

Other Documents

Keep reading

More on IQV

Trending in the feed

Open the live feed